Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

Clinical study to show if Naronapride tablets are safe and efficient for treatment of delayed stomach emptying and to find the optimal dose. Ended

2023-510195-31-00 Idiopathic or Diabetic Gastroparesis 4 2023-01-03
An Open Label Study to Evaluate A3907 in Adults with Primary Sclerosing Cholangitis (PSC) Ended

2022-500790-14-00 Primary Sclerosing Cholangitis (PSC) 4 2023-01-02
An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condi… Ended

2022-502200-67-00 Non-small Cell Lung Cancer 3 2022-12-27
Ezurpimtrostat autophagy inhibitor in association with Atezolizumab-Bevacizumab in first line treatment of unresectable hepatocellular carci… Ended

2022-502078-17-00 unresectable hepatocellular carcinoma 4 2022-12-15
A phase II, national, multicenter, uncontrolled and open trial to evaluate the feasibility and safety of lamparoscopic administration of all… Ended

2023-507108-30-00 Crohn's disease 4 2022-10-22
Zibotentan and Dapagliflozin combination, Evaluated in Liver cirrhosis (ZEAL study) Ended

2023-505405-17-00 Liver cirrhosis with features of portal hypertension. 4 2022-10-07
Nivolumab during active surveillance after neoadjuvant chemoradiation for esophageal cancer: SANO-3 study Ended

2024-513635-24-00 oesophageal cancer 10 2022-09-29
Tramadol OIBD Ended

2022-500108-23-00 Opioid induced bowel dysfunction 6 2022-08-08
A Phase 2a study to evaluate the Efficacy, Safety, and Tolerability of MORF-057 in Ulcerative Colitis Ended

2024-516960-27-00 Moderately to severely active ulcerative colitis 4 2022-07-22
A Phase 2 Trial of SCO-101 in combination with FOLFIRI for Patients with Metastatic Colorectal Cancer (mCRC) with acquired Resistance to FOL… Ended

2024-518877-33-00 Metastatic Colorectal Cancer 4 2022-03-17
Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative Colitis Ended

2023-506004-93-00 Ulcerative Colitis (UC) 4 2022-03-01
A study to test whether BI 706321 combined with ustekinumab helps people with Crohn's Disease Ended

2024-512756-38-00 Crohn`s Disease (CD) 4 2022-02-17
VTX002 versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis Ended

2023-509233-39-00 Moderately to Severely Active Ulcerative Colitis 4 2022-01-20
EvAluation of the efficacy of MaaT013 as salvage theRapy in acute GVHD patiEntS with gastrointestinal involvement, refractory to ruxolitinib… Ended

2024-513023-17-00 Treatment of acute graft-versus host disease (aGvHD) to 5 2022-01-12
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Ended

2023-509018-12-00 Moderately to severely active Ulcerative Colitis (UC) 5 2021-12-17
A clinical study of tulisokibart in people with Crohn’s disease (MK-7240-006) Ended

2023-509742-35-00 Crohn's disease 4 2021-11-17
Evaluation of the personalised treatment of colorectal cancer by regorafenib based on therapeutic and pharmacological monitoring Ended

2024-517241-13-00 metastatic colorectal cancer 4 2021-10-22
Clinical Outcomes, Tolerability and Safety of Oral Pantoprazole in Pediatric Participants Ended

2023-508770-28-00 EROSIVE ESOPHAGITIS 4 2021-10-05
A clinical study of tulisokibart for the treatment of ulcerative colitis (MK-7240-005) Ended

2023-509741-12-00 Ulcerative Colitis 4 2021-09-23
Research study on whether a combination of 2 medicines (NNC0194-0499 and Semaglutide) works in people with non-alcoholic steatohepatitis (NA… Ended

2023-506961-74-00 Non-alcoholic steatohepatitis (NASH) 4 2021-08-31
A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan… Ended

2024-513569-38-00 Crohn's Disease 10 2021-07-09
EASE SBS 3 (Evaluation of the efficacy and safety of Glepaglutide in the treatment of short bowel syndrome (SBS) Ended

2024-513373-43-00 Short bowel syndrome 5 2021-06-11
A Phase 3 Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with… Ended

2023-503973-39-00 Complex Perianal Fistulas in Crohn's Disease 5 2021-03-16
VERDICT - Optimal Treatment Target in Active Ulcerative Colitis (UC) Ended

2024-514183-21-00 Ulcerative colitis 6 2021-01-15